Artiva Biotherapeutics, Inc. Common Stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -83%. Total operating expenses were $64,163,000.
Profit Margin
| 2020 | 0 | -17.99M | |
|---|---|---|---|
| 2023 | 33.49M | -27.69M | -82.69% |
ARTV Income Statement (2020 – 2023)
| 2023 | 2020 | |
|---|---|---|
Revenue | ||
Revenue | 33.49M | 0 |
Cost of revenue | 0 | 0 |
Gross profit | 33.49M | 0 |
Operating exp. | ||
Research and development | 50.25M | 13.84M |
Selling and marketing | 0 | 0 |
Total operating expenses | 64.16M | 18.27M |
Operating income | -30.67M | -18.27M |
Other income (expenses), net | 3.04M | 280K |
Income before tax | -27.62M | -17.99M |
Income tax expense | 72K | 676K |
Net income | -27.69M | -17.99M |
Earnings per share | ||
Basic EPS | -2.96 | -1.02 |
Diluted EPS | -2.96 | -1.02 |